Skip to main content
    Z

    Zura Bio Limited Class A Ordinary Shares (ZURA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.08
    -0.16 (-12.90%)

    Market Cap: $119.44M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Zura Bio Limited Class A Ordinary Shares (ZURA) Financials: Revenue, Profit and Cash Flow

    Updated Oct 27, 2026. Financial statements from company filings, amounts in US dollars.

    Zura Bio Limited Class A Ordinary Shares reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$68.65M, operating cash flow was -$64.81M and free cash flow was -$64.93M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$25.82M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $75.25M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021N/AN/AN/AN/AN/A
    Annual, fiscal years ended Dec 2021 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
    Research and development$42.08M$24.40M$44.00M$0$0
    Operating income-$75.25M-$55.19M-$62.64M-$2.68M-$1.09M
    Net income-$68.65M-$52.40M-$60.36M$3.55M$8.42M
    EBITDA-$74.94MN/AN/A$1.47M$8.42M
    Fiscal years ended Dec 2021 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$0$0$0$0$0$0$2.00K$0$0$0$0
    Gross profit$0$0$0-$15.00K$0$0$0-$5.00K$0$0$0N/A
    Operating income-$28.77M-$29.32M-$25.50M-$18.41M-$19.52M-$18.06M-$19.25M-$15.73M-$19.32M-$11.76M-$8.38M-$10.83M
    Net income-$25.82M-$26.30M-$24.22M-$17.18M-$18.04M-$15.99M-$17.44M-$13.63M-$20.70M-$10.33M-$7.75M-$8.47M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents of $109.41M were 96.0% of total assets of $113.95M, against total liabilities of $12.41M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
    Total assets$113.95M$179.53M$100.84M$5.26M$140.55M
    Current assets$112.31M$178.74M$100.84M$1.78M$1.15M
    Cash and equivalents$109.41M$176.50M$99.81M$1.57M$729.22K
    Total liabilities$12.41M$19.51M$21.29M$14.82M$10.35M
    Short-term debtN/AN/AN/A$7.76M$0
    Shareholder equity$101.54M$146.81M$59.33M-$32.06M-$9.18M
    Fiscal years ended Dec 2021 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$194.63M$213.40M$228.64M$113.95M$143.94M$157.81M$172.50M$179.53M$189.07M$189.50M$90.48M$100.84M
    Total liabilities$16.97M$16.32M$11.74M$12.41M$25.49M$18.70M$21.09M$19.51M$18.24M$17.44M$16.27M$21.29M
    Cash and equivalents$187.65M$205.13M$225.59M$109.41M$139.02M$154.49M$170.57M$176.50M$188.22M$188.44M$89.82M$99.81M
    Shareholder equity$177.66M$197.09M$216.90M$101.54M$108.24M$125.91M$138.20M$146.81M$153.05M$156.52M$61.01M$59.33M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
    Operating cash flow-$64.81M-$28.08M-$15.05M-$1.07M-$1.10M
    Capital expenditures$113.00K$75.00K$0$12.00M$4
    Free cash flow-$64.93M-$28.15M-$15.05M-$13.07M-$1.10M
    Share repurchases$0$626.00K$0$0N/A
    Investing cash flow-$113.00K-$5.08M-$8.00M$0-$139.38M
    Financing cash flow-$2.16M$109.84M$121.29M$355.60K$141.21M
    Fiscal years ended Dec 2021 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$19.50K$18.88M-$18.92M-$22.28M-$15.44K$11.04M-$11.06M-$10.82M-$5.65M-$6.62M-$4.98M-$4.05M
    Capital expenditures$36$12.96K$13.00K$17.00K$32$48.94K$49.00K$45.00K$13.00K$10.00K$7.00K$0
    Free cash flow-$19.53K$18.87M-$18.94M-$22.30M-$15.48K$10.99M-$11.11M-$10.87M-$5.67M-$6.63M-$4.99M-$4.05M
    Last 12 quarters

    Frequently Asked Questions About ZURA

    What is Zura Bio Limited Class A Ordinary Shares' annual revenue?

    Zura Bio Limited Class A Ordinary Shares reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is Zura Bio Limited Class A Ordinary Shares profitable?

    No. Zura Bio Limited Class A Ordinary Shares reported net income of -$68.65M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does ZURA generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$64.81M minus capital expenditures of $113.00K produced free cash flow of -$64.93M.

    How much debt does Zura Bio Limited Class A Ordinary Shares have?

    The balance sheet dated Dec 31, 2025 reported cash and equivalents of $109.41M.